Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

Arnon Nagler; Myriam Labopin; Jonathan Canaani; Riitta Niittyvuopio; Gerard Soci; Nicolaus Kroeger; Maija Itälä-Remes; Ibrahim Yakoub-Agha; Helene Labussiere-Wallet; Maria P. Gallego-Hernanz; Eric Deconinck; Patrice Chevallier; Juergen Finke; Jordi Esteve; Mohamad Mohty

doi:10.1002/ajh.25905

Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

Arnon Nagler, Myriam Labopin, Jonathan Canaani, Riitta Niittyvuopio, Gerard Soci, Nicolaus Kroeger, Maija Itälä-Remes, Ibrahim Yakoub-Agha, Helene Labussiere-Wallet, Maria P. Gallego-Hernanz, Eric Deconinck, Patrice Chevallier, Juergen Finke, Jordi Esteve, Mohamad Mohty

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	American Journal of Hematology
Volume	95
Issue number	10
Pages (from-to)	1135-1141
Number of pages	7
ISSN	0361-8609
DOIs	https://doi.org/10.1002/ajh.25905
Publication status	Published - Oct 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

ACUTE MYELOID-LEUKEMIA
HEMATOPOIETIC-CELL TRANSPLANTATION
STANDARD-RISK
SURVIVAL
RELAPSE
AML
NPM1
DIAGNOSIS
OUTCOMES
ALWP
INTENSITY
3122 Cancers

Access to Document

10.1002/ajh.25905

Cite this

Nagler, A., Labopin, M., Canaani, J., Niittyvuopio, R., Soci, G., Kroeger, N., Itälä-Remes, M., Yakoub-Agha, I., Labussiere-Wallet, H., Gallego-Hernanz, M. P., Deconinck, E., Chevallier, P., Finke, J., Esteve, J., & Mohty, M. (2020). Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation. American Journal of Hematology, 95(10), 1135-1141. https://doi.org/10.1002/ajh.25905

Nagler, Arnon ; Labopin, Myriam ; Canaani, Jonathan et al. / Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission : On behalf of the acute leukemia working party of the European society for blood and marrow transplantation. In: American Journal of Hematology. 2020 ; Vol. 95, No. 10. pp. 1135-1141.

@article{493c4e9076cd459abbdedb243b12a000,

title = "Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation",

keywords = "ACUTE MYELOID-LEUKEMIA, HEMATOPOIETIC-CELL TRANSPLANTATION, STANDARD-RISK, SURVIVAL, RELAPSE, AML, NPM1, DIAGNOSIS, OUTCOMES, ALWP, INTENSITY, 3122 Cancers",

author = "Arnon Nagler and Myriam Labopin and Jonathan Canaani and Riitta Niittyvuopio and Gerard Soci and Nicolaus Kroeger and Maija It{\"a}l{\"a}-Remes and Ibrahim Yakoub-Agha and Helene Labussiere-Wallet and Gallego-Hernanz, {Maria P.} and Eric Deconinck and Patrice Chevallier and Juergen Finke and Jordi Esteve and Mohamad Mohty",

year = "2020",

month = oct,

doi = "10.1002/ajh.25905",

language = "English",

volume = "95",

pages = "1135--1141",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley",

number = "10",

}

Nagler, A, Labopin, M, Canaani, J, Niittyvuopio, R, Soci, G, Kroeger, N, Itälä-Remes, M, Yakoub-Agha, I, Labussiere-Wallet, H, Gallego-Hernanz, MP, Deconinck, E, Chevallier, P, Finke, J, Esteve, J & Mohty, M 2020, 'Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation', American Journal of Hematology, vol. 95, no. 10, pp. 1135-1141. https://doi.org/10.1002/ajh.25905

Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation. / Nagler, Arnon; Labopin, Myriam; Canaani, Jonathan et al.
In: American Journal of Hematology, Vol. 95, No. 10, 10.2020, p. 1135-1141.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission

T2 - On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

AU - Nagler, Arnon

AU - Labopin, Myriam

AU - Canaani, Jonathan

AU - Niittyvuopio, Riitta

AU - Soci, Gerard

AU - Kroeger, Nicolaus

AU - Itälä-Remes, Maija

AU - Yakoub-Agha, Ibrahim

AU - Labussiere-Wallet, Helene

AU - Gallego-Hernanz, Maria P.

AU - Deconinck, Eric

AU - Chevallier, Patrice

AU - Finke, Juergen

AU - Esteve, Jordi

AU - Mohty, Mohamad

PY - 2020/10

Y1 - 2020/10

KW - ACUTE MYELOID-LEUKEMIA

KW - HEMATOPOIETIC-CELL TRANSPLANTATION

KW - STANDARD-RISK

KW - SURVIVAL

KW - RELAPSE

KW - AML

KW - NPM1

KW - DIAGNOSIS

KW - OUTCOMES

KW - ALWP

KW - INTENSITY

KW - 3122 Cancers

U2 - 10.1002/ajh.25905

DO - 10.1002/ajh.25905

M3 - Article

SN - 0361-8609

VL - 95

SP - 1135

EP - 1141

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 10

ER -

Nagler A, Labopin M, Canaani J, Niittyvuopio R, Soci G, Kroeger N et al. Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation. American Journal of Hematology. 2020 Oct;95(10):1135-1141. Epub 2020 Jul 9. doi: 10.1002/ajh.25905